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Abstract: The bacterial outer membrane (OM) is a peculiar biological structure with a 
unique composition that contributes significantly to the fitness of Gram-negative bacteria 
in hostile environments. OM components are all synthesized in the cytosol and must, then, 
be  transported  efficiently  across  three  compartments  to  the  cell  surface. 
Lipopolysaccharide (LPS) is a unique glycolipid that paves the outer leaflet of the OM. 
Transport  of  this  complex  molecule  poses  several  problems  to  the  cells  due  to  its 
amphipatic nature. In this review, the multiprotein machinery devoted to LPS transport to 
the OM is discussed together with the challenges associated with this process and the 
solutions that cells have evolved to address the problem of LPS biogenesis. 
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1. Introduction 
All living cells are surrounded by the cytoplasmic membrane, a unit membrane of which overall 
architecture, a fluid lipid bilayer with integral and peripheral membrane proteins, is conserved among 
the  three  domains  of  life  Bacteria,  Archaea, and  Eukarya.  The  importance  of  such  a  structure  is 
underlined by the notion that everything that exists outside of the biological membrane is non-living. 
Outside of the universally conserved cytoplasmic membrane, prokaryotes have developed complex 
architectures, collectively named the cell wall, which provide additional strength, contribute to the cell 
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shape  determination,  and  allow  them  to  face  unpredictable  and  often  hostile  environmental  
insults [1–3]. Many Bacteria are surrounded by an additional lipid bilayer, the outer membrane (OM), 
and are, thus, described as diderm bacteria. The OM is not present in monoderm bacteria, which 
possess the cytoplasmic membrane as the unique lipid membrane [4–6]. 
The OM is an essential structure that has been extensively studied over the last half century in 
Proteobacteria  phylum  and  particularly  in  Enterobacteriaceae,  it  possesses  a  peculiar  asymmetric 
structure due to the presence of a complex glycolipid, the lipopolysaccharide (LPS), in the outer leaflet 
of the lipid bilayer, whereas the inner leaflet is composed of phospholipids. OM proteins (OMPs) and 
lipoproteins are also embedded and anchored, respectively, in the OM [7]. The space in between IM 
and OM is an aqueous compartment, the periplasm, which contains a peptidoglycan layer, a large cell 
polymer  that  surrounds  the  bacterial  cell  [8,9].  This  cellular  exoskeleton  is  the  main  structure 
responsible for the cell shape and the mechanical strength and elasticity of the bacterial envelope [10]. 
The presence of a highly structured OM poses several problems for its biogenesis. Both lipid and 
protein components must not only be synthesized in the cytoplasm and/or at the inner membrane (IM) 
level and translocated across the IM lipid bilayer, but must also traverse the aqueous periplasmic space 
and be assembled at the amphypathic final destination. The cell compartments external to the IM are 
devoid of ATP and other high-energy carriers [11]. As a consequence the energy to build up OM 
structures is either provided by exergonic reactions (thus involving substrates that have been energized 
before  their  translocation  across  the  IM)  or  transduced  by  devices  (usually  protein  machines) 
connected to the IM and capable to exploit the energy released by ATP hydrolysis in the cytoplasm or 
the proton motive force. 
This review, after a short overview on the OM structure and functions will focus on its peculiar 
component, the LPS. First LPS structure and biosynthetic pathway will be briefly discussed. Then, the 
machinery  that  ferries  LPS  from  the  IM  to  its  final  destination  in  the  OM  together  with  recent 
advances in the molecular mechanisms of LPS export will be reviewed in more details. 
2. Overview of OM Structure and Functions 
Several  structural  and  functional  aspects  differentiate  the  OM  from  the  cytoplasmic  membrane 
(IM). The most striking structural difference is the asymmetry of the OM bilayer as the periplasmic 
side is made by a layer of the same type of phospholipids that compose both leaflets of the IM, 
whereas LPS constitutes the OM layer facing the environment outside the cell. The unique chemical 
structure  and  properties  of  LPS,  as  discussed  in  below,  are  mainly  responsible  of  the  peculiar 
properties of the OM. Indeed, the presence of this peculiar glycolipid in the outer leaflet of the OM, 
endows Gram-negative bacteria with a strong permeability barrier, which accounts for the generally 
higher  resistance  of  Gram-negative  bacteria,  as  compared  to  most  Gram-positives,  to  many  toxic 
chemicals  such  as  antibiotics  and  detergents  (e.g.,  bile  salts),  thus,  allowing  survival  in  hostile 
environments  (e.g.,  gastrointestinal  tracts  of  mammals)  encountered  during  host  colonization  or 
infection [12,13]. 
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2.1. OM Proteins and Lipoproteins 
Cell-environment exchanges across the OM are ensured by OM proteins  (OMPs) implicated in 
several functions, such as nutrients uptake, transport, and secretion of various molecules (proteins, 
polysaccharides, drugs). While integral IM proteins are typically composed of α-helical bundles [14] 
the vast majority of OMPs are integral proteins that assume a β-barrel topology [15]. OM-associated 
proteins are generally lipoproteins that are anchored to the periplasmic side of the OM via a lipid tail 
attached to an N-terminal cysteine residue [16]. In Escherichia coli the majority of lipoproteins are 
OM associated, and only a minor fraction faces the periplasm by IM anchoring. The most abundant 
lipoprotein in E. coli is Lpp (or Braun’s protein) that anchors the peptidoglycan layer to the OM [17]. 
OMPs and lipoproteins are synthesised as pre-proteins in the cytoplasm and then secreted across the 
IM by the SEC translocase a universally conserved machine that transport unfolded proteins [18]. 
Following translocation, lipoproteins are processed into mature forms on the periplasmic side of 
cytoplasmic membrane where a lipid moiety is attached to the N terminus to anchor these proteins to 
the membrane. [16]. Lipoprotein sorting has been extensively studied in E. coli where their traffic 
system is essential for growth [19,20]. Indeed in E. coli lipoproteins play vital roles in OM sorting of 
OMPs, LPS and lipoprotein themselves [3]. Lipoproteins with OM location are transported by the 
dedicated Lol system (LolABCDE) composed by five essential proteins. LolCDE constitute an ABC 
transporter  that  initiates  sorting  by  mediating  the  detachment  of  lipoproteins  from  the  IM  and 
transferring them to the periplasmic chaperone LolA. The water-soluble lipoprotein-LolA complex 
crosses the periplasm and at the OM LolA transfers its cargo to LolB for incorporation into the lipid 
bilayer [20]. 
Once secreted across the IM, misfolding of β-barrel OM proteins precursors in the periplasm is 
prevented by molecular chaperones, such as SurA and Skp [21], which assists OMPs transport across 
the  periplasm  and  deliver  them  to  the  BAM  complex  a  molecular  machine  driving  β-barrel  
assembly [22]. The Bam machinery is composed by the essential BamA OMP that work in complex 
and is tightly associated with four lipoproteins partners BamB, BamC, BamD, and BamE. The Bam 
complex may be viewed as a modular molecular machine in which BamA forms the protein:lipid 
interface at which OMP substrates enter into the lipid phase of the membrane. BamB interacts with 
BamA and is proposed to form a scaffold to assist β-barrel folding. BamB, BamC, and BamD interact 
and form a module suggested to drive a conformational switch in the BAM complex that enables  
β-barrel insertion into the OM [22]. 
2.2. LPS Structure and Function 
LPS is typically organized into three structural domains: lipid A, a core oligosaccharide and a 
highly variable O-antigen constituted of repeating oligosaccharide units (Figure 1) [23]. The core is 
covalently linked to lipid A and can be further divided into inner (lipid A proximal) and outer core. 
The chemical structure of the outer core is variable, whereas the inner core tends to be quite conserved 
and in all species so far analyzed, it contains at least one residue of 3-deoxy-D-manno-oct-2 ulosonic 
acid (Kdo) linking the inner core to lipid A. Therefore, Kdo is a chemical hallmark of LPS and a Mar. Drugs 2014, 12  1026 
 
 
marker of LPS-producing Gram-negative bacteria [24]. The O-antigen is the distal, surface exposed 
LPS moiety responsible of the immunogenic properties of this macromolecule [23]. 
LPS  is  essential  in  most  Gram-negative  bacteria  with  the  notable  exception  of  Neisseria  
meningitidis [25]. The LPS structural requirements for bacterial viability however, may vary across 
genera/species.  In  E.  coli  the  minimal  LPS  structure  required  for  growth  has  been  defined  as  
Kdo2-lipid A [23], although the lethal phenotype of Kdo-deficient mutants may be rescued by several 
suppressor mutations [26]. In contrast, Pseudomonas aeruginosa, in addition to lipid A, requires the 
full inner core and at least part of the outer core to be viable [27,28]. The structural complexity of LPS 
reflects the multiple functions displayed by this macromolecule. While the outer hydrophilic layer of 
LPS leaflet in the OM represents an effective barrier for passive diffusion of lipophilic compounds, the 
lipid A moiety, together with the phospholipids of the internal leaflet, forms a hydrophobic barrier. 
Moreover, LPS appears tightly packed at the outer OM leaflet as strong lateral interaction between 
LPS molecules occurs by the bridging action of Mg
2+ and Ca
2+ divalent cations, thus, counteracting the 
negative repulsive charges and stabilizing the structure [12,24]. 
LPS is also a potent activator of the innate immune response and lipid A (also known as endotoxin) 
represents the conserved pathogen associated molecular pattern (PAMP) recognized by innate immune 
receptors  to  signal  and  activate  complex  signaling  cascades  that  lead  to  the  release  of  
pro-inflammatory cytokines [29]. Recognition of lipid A requires the TLR4-MD2 complex [30,31] and 
the accessory protein CD14 and LPB (LPS binding protein) [32]. 
2.3. Overview of LPS Biosynthesis 
The biosynthesis of LPS is a complex process that occurs in three different cellular compartments, 
cytoplasm, IM and periplasm, thus, requiring spatial and temporal coordination of several independent 
biosynthetic pathways (lipid A, Kdo, and oligosaccharide core) that converge in an ordered assembly 
line to give the mature molecule (Figure 1) [23,33,34]. Nine enzymes are required to for the synthesis 
of the Kdo2-lipid A moiety. The first reaction in the synthesis of lipid A is the fatty acylation of  
UDP-N-acetyglucosamine (UDP-GlcNAc) by LpxA to UDP-3-O-acyl-GlcNAc that is deacetylated by 
the  LpxC  enzyme  [35].  Further  acylation  is  then  carried  out  by  LpxD  the  third  enzyme  of  the 
biosynthetic machinery. In both acylation steps catalyzed by LpxA and LpxD the fatty acyl donor is  
R-3–hydroxymyristoyl  ACP  that  also  serves  as  an  acyl  donor  for  the  synthesis  of  membrane 
phospholipids  and  therefore  represents  a  crucial  metabolic  branch  point  in  the  biosynthesis  of 
membrane components [36,37]. Next, reactions catalyzed by LpxH, LpxB, and LpxK result in the 
synthesis  of  the  tetra-acylated  lipid  IVA  that,  in  E.  coli,  is  the  substrate  of  WaaA  the  CMP-Kdo 
dependent transferase that catalyzes the sequential incorporation of two Kdo residues synthesized in a 
separate  pathway  [23].  Finally, the late acyltransferases  LpxL and  LpxM catalyze the addition of 
secondary acyl chains to the distal glucosamine [38,39] to give the hexa-acylated Kdo2-lipid A moiety. 
The  additional  sugars  composing  the  oligosaccharide  core  are  added  to  Kdo2-lipid  A  by  specific 
glycosyl-transferases to generate the core-lipid A structure. 
The  core-lipid  A,  which  is  anchored  to  the  IM  with  its  hydrophilic  moiety  exposed  to  the 
cytoplasm, is then flipped over the IM by the ABC transporter MsbA and becomes exposed in the 
periplasm [40,41]. O-antigen repeat units are synthesized in the cytoplasm and then flipped at the Mar. Drugs 2014, 12  1027 
 
 
periplasmic face of the IM attached to the lipid carrier undecaprenyl diphosphate. Mature LPS is then 
formed at the periplasmic side of the IM by the WaaL ligase that catalyzes the ligation of O-antigen to 
core-lipid A [42]. The O-antigen moiety is not essential and is missing in common laboratory E. coli 
K12 strains due to inactivation of the wbbL gene [43,44] but is present in most wild type strains and 
clinical isolates where it contributes to virulence by protecting the bacteria from phagocytosis and 
complement-mediated killing [45]. 
Figure 1. LPS biosynthesis in E. coli K12 strains. Cytoplasm and inner leaflet of IM: lipid 
IVA is synthesized from two molecules of the sugar nucleotide UDP-GlcNAc. Sequential 
addition of two Kdo molecules to lipid IVA produces the Kdo2-lipid IVA moiety which 
undergoes  two  late  acylation  reactions  to  give  Kdo2-lipid  A.  Core  oligosaccharide  is 
assembled  on  Kdo2-lipid  A  via  sequential  glycosyl  transfer  from  nucleotide  sugar 
precursors.  Outer  leaflet  of  IM:  core-lipid  A  is  translocated  across  the  IM  by  MsbA 
transporter.  Schematic  representation  of  core  lipid  A:  violet  rectangle,  Kdo;  yellow 
heptagon,  heptose;  red  hexagon,  glucose;  orange  hexagon,  galactose.  In  the  inset  the 
chemical structure of E. coli K12 LPS is shown. 
 
The  enzymes  for  lipid  A  and  Kdo  biosynthesis  are  constitutively  expressed  [23,46].  However,  
in  E.  coli  the  production  of  Kdo2-lipid  A  is post-transcriptionally regulated  by FtsH,  an  essential 
membrane protease belonging to the AAA family (ATPase associated with various cellular activities) 
that controls the turnover of LpxC [47] the enzyme that catalyzes the first committed step of the lipid 
A biosynthetic pathway [48]. Mutations in ftsH lead to increased cellular levels of LpxC and are  
lethal [47]. This can be explained by the fact that both lipid A and phospholipid biosynthetic pathways Mar. Drugs 2014, 12  1028 
 
 
largely depend on the same precursor molecule, R-3–hydroxymyristoyl ACP. The increased level of 
LpxC  may,  thus,  effectively  deplete  the  R-3–hydroxymyristoyl  ACP  pool,  thus,  leading  to  an 
imbalanced phospholipid/LPS ratio in the OM [47]. FtsH also controls the turnover of WaaA, the 
enzyme  catalyzing  incorporation  of  Kdo  residues  in  lipid  IVA  [49].  Therefore  FtsH  dependent 
proteolysis seems to be a crucial point of control to balance the levels of membrane lipid synthesis 
according to the physiological state/growth conditions of the cell. Indeed it has been recently reported 
that LpxC is degraded rapidly during slow growth, presumably to avoid toxic overproduction of LPS, 
and  that  the  alarmone  ppGpp  is  needed  together  with  FtsH  to  control  LpxC  stability  [50].  Very 
recently an additional player of this regulatory mechanism, YciM a conserved tetratricopeptide repeat 
protein,  has  been  identified.  YciM  is  essential  and  its  depletion  results  in  increased  LpxC  levels 
leading to higher amount of LPS and, ultimately, to cell death suggesting that FtsH proteolytic activity 
is also modulated by YciM [51]. Control of LPS biosynthesis by FtsH mediated proteolysis, however, 
is not a widespread mechanism across Gram-negative bacteria but seems restricted to Enterobacteria; 
indeed  the  C-terminus  of  LpxC  (where  sequence  specific  degradation  signals  are  located)  differs 
significantly among species whereas the overall sequence of LpxC is highly conserved [52]. 
3. LPS transport to the Outer Membrane 
3.1. The Lpt Machinery: Structure and Organization of the Components across IM and OM 
Following  MsbA  dependent  translocation  [40,41]  the  mature  LPS  molecule  assembled  at  the 
periplasmic face of the IM by WaaL ligase must traverse the aqueous periplasmic compartment before 
being inserted and correctly assembled at the OM. 
The transport of LPS across the periplasm has been studied mainly in E. coli and N. meningitidis.  
In  E. coli  the  Lpt (lipopolysaccharide  transport)  complex  is composed  of seven essential proteins 
(LptABCDEFG) [53–56] that are located in every cellular compartment: cytoplasm, IM, periplasm, 
and OM (Figure 2). The Lpt complex provides energy for LPS extraction from the IM and mediates its 
transport across the aqueous periplasm and its insertion and assembly at the OM [3,57,58]. 
The Lpt machinery may be divided in three subassemblies: LptBFGC, LptA, and LptDE, which are 
located at the IM, in the periplasm, and at the OM, respectively. LptBFG [56,59,60] constitute an IM 
ABC transporter that is associated to an atypical subunit, the bitopic IM protein LptC [61], whose 
function in the ABC transporter has not yet been clarified [60]. LptB is the ATP binding domain of 
this transporter [62] and LptF and LptG represent the transmembrane subunits. At the OM the LptDE 
translocon composed by the β-barrel protein LptD and the lipoprotein LptE is responsible of the final 
stage  of  LPS  assembly  at  the  cell  surface  [55,63].  The  periplasmic  protein  LptA  has  the  role  of 
connecting the two sub-complexes, somehow coordinating their functions [59,64]. 
The Lpt machinery appears to work as a singe device as depletion of any components leads to 
similar phenotypes namely block of LPS transport and its accumulation to the periplamic side of the 
IM where it is decorated by colanic acid by the WaaL ligase [56,61]; such LPS modification appears to 
be diagnostic of defects in the LPS export pathway [57]. Indeed all the seven proteins physically 
interact and form a transenvelope complex spanning IM and OM [65]. 
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Figure 2. Overview of OMPs and LPS biogenesis pathways and extracytoplasmic stress 
response. (a) OMPs are synthesized in the cytoplasm and translocated across the IM by the 
Sec translocon. After translocation, the signal sequence (indicated in red) is cleaved. In the 
periplasm,  chaperone  proteins  as  SurA  assist  OMPs  folding  and  deliver  them  to  the 
BamABCDE complex for assembly at the OM. Blue arrows show the sequence of events 
occurring during OMPs biogenesis. (b) LptD is an OMP and follows the chaperone/Bam 
folding pathway. Correct LptD folding requires its association with the lipoprotein LptE 
and  interdomain  disulfide  bridges  isomerization.  LptD-LptE  interaction  at  the  Bam 
complex  is  favored  by  the  chaperone/protease  BepA.  Red  dashed  arrows  show  the 
sequence of events occurring during LptDE complex assembly. (c) LptDE complex is the 
LPS OM translocon. LPS is synthesized in the cytoplasm by the Lpx pathway, flipped to 
the periplasmic face of the IM by MsbA and transported through the periplasm to the outer 
leaflet of the OM by the Lpt machinery. Continuous red arrows show the sequence of 
events occurring during LPS biogenesis. (d) Mislocalized or misfolded OMPs and defects 
in  the  LPS  export  pathway  trigger  the  σ
E  envelope  stress  response  (black  arrows). 
Misassembled porins bind to DegS, cleaving RseA and initiating the σ
E stress response. 
The current model suggests that defects in Lpt assembly/function result in RseB binding to 
LPS possibly released by the Lpt machinery (question mark). RseB bound to LPS frees 
RseA that can then be cleaved by OMP-activated DegS and by RseP thus activating the σ
E 
stress response. 
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3.2. Molecular Mechanism of Lpt Transport: Towards the Transenvelope Bridge Model 
LPS is an amphipatic molecule, this implies that its transport across the periplasm cannot occurs by 
simple  diffusion  and  requires  at  least  two  energy  inputs:  one  for  its  extraction  from  the  lipid 
environment of the IM, and one to facilitate the transit of the hydrophobic lipid A portion through the 
aqueous environment of the periplasm. Since the discovery of the first Lpt factors, this notion induced 
researchers to postulate different working models to describe the mechanism of LPS transport. 
Based  on  the  fact  that  every  envelope  compartment  has  at  least  one  factor  dedicated  to  LPS 
transport [56,61], two main models have been considered: the chaperone-mediated transit across the 
periplasm and the transport through a transenvelope proteinaceous bridge spanning both IM and OM. 
According to the first model, LptA would be the soluble carrier that accepts LPS from LptBFGC, 
forms a soluble complex shielding its hydrophobic moiety during the diffusion across the periplasm 
and, ultimately, delivers it to the OM complex LptDE. As such, LptA would function in the same 
fashion of LolA, the periplasmic chaperone involved in OM lipoprotein trafficking (see above) [20]. 
By analogy with LolA, the three-dimensional structure of LptA reveals a novel fold resembling a 
semiclosed β-jellyroll with an internal hydrophobic cavity [66], compatible with a role in hosting and 
shielding hydrophobic molecule portions. In fact, LptA binds LPS in vitro and in vivo [67,68] and can 
displace it from LptC, in line with their subcellular locations and the unidirectionality of the transport 
(from  IM  to  OM)  [67–69].  However,  alongside  the  analogies  there  are  also  some  substantial 
differences between Lol and Lpt system: first of all, a recent work from Kahne’s group demonstrated 
that, unlike LolA, physiologically expressed LptA is not a soluble periplasmic protein but fractionates 
with both IM and OM in sucrose density gradient centrifugation [65]. Moreover, in vitro, LptA shows 
the propensity to form oligomeric fibrils [66,70]. LptA association to both IM and OM thus suggests 
that in vivo the protein does not function as a soluble carrier but form oligomeric structures spanning 
the width of the periplasm. This is in agreement with previous evidence that LPS transport occurs in 
spheroplast, where the periplasmic soluble content has been drained, and that soluble LPS-protein 
complexes have never been isolated from periplasm [71]. Another remarkable difference between Lol 
and Lpt system lies in the atypical LptC subunit of the ABC transporter LptBFG. LptC is a bitopic 
LPS binding protein whose three-dimensional structure closely resembles the LptA fold, despite the 
low sequence similarity between the two proteins [69]. LptC stably associates to the LptBFG complex, 
but in vitro does not affect the ATPase activity of the transporter [60], making obscure its role in LPS 
export. Overall, the balance between differences and analogies with the Lol mechanism of transport 
makes the chaperone-assisted LPS export model unlikely. 
The second model for LPS transport suggests the existence of a molecular machine made up of 
individual protein components located in each cellular compartment thus connecting IM and OM. 
These molecular machines are not unusual structures in Gram-negative bacteria. Examples are the 
efflux pumps, responsible for antibiotic resistance in pathogenic bacteria [72], or the Type III secretion 
systems, whose function is to inject toxins into the infected host cells [73]. 
The most important evidence supporting this model is that depletion of any Lpt factor leads to 
accumulation of de novo synthesized LPS at the periplasmic side of the IM [61]. This suggests that the 
Lpt  proteins  constitute  a  molecular  machine  that  operates  as  a  single  device  downstream  of  
MsbA-mediated LPS flipping across the IM (see above). In line with this model, a recent work from Mar. Drugs 2014, 12  1031 
 
 
Kahne’s  group  demonstrated  that  the  Lpt  proteins  co-fractionate  in  sucrose  density  gradient 
centrifugation in a lighter OM fraction (referred to as OML) containing IM and OM components and 
that  these  proteins  all  physically  interact  to  form  a  transenvelope  bridge  [65].  The  finding  that 
mutations  impairing  Lpt  complex  assembly  result  in  degradation  of  the  periplasmic  component 
LptA [74], confirms the biological relevance of the transenvelope structure in vivo. 
Interestingly, the transenvelope model of transport is reminiscent of a model postulated more than 
40 years ago by Manfred E. Bayer, who based on transmission electron micrographs of plasmolysed 
cells suggested the existence of lipid bridges connecting IM and OM with the function of facilitating 
the transit of hydrophobic molecules as LPS across the aqueous periplasmic compartment [75,76]. 
Although initially controversial, this hypothesis obtained confirmations in two studies published some 
years  later  demonstrating  the  existence  of  zones  of  adhesion  between  IM  and  OM  where  newly 
synthesized LPS transiently appears during cell growth [77]. These structures were then isolated as a 
lighter OM fraction (the same OML fraction described later by Kahne and co-workers) containing IM 
and OM components along with murein [78]. 
To date, the evidence of the existence of these bridges made up of proteins appears definitive. 
However, some issues concerning the molecular mechanism of LPS transport mediated by the Lpt 
system still need to be clarified: first, how do the Lpt proteins physically favor the transit of LPS 
across the periplasm? And second, is the ATP hydrolysis needed to assemble the bridge or is it only 
required to extract the LPS from the IM? 
Some clues about the mechanism by which the transenvelope protein machine physically favors 
LPS transit through the periplasm arose from recent work by Kahne’s group exploiting the powerful 
tool of the photo-crosslinking in vivo. This chemical approach allows the identification of protein 
residues involved in protein-protein or protein-ligand interactions by labeling the proteins of interest  
in vivo with an UV reactive cross-linkable aminoacid analog [79,80]. 
Using this method the authors demonstrated that LptE, which was previously found to reside within 
the  lumen  of  the  β-barrel  of  LptD  [63],  interacts  directly  with  some  residues  of  a  predicted 
extracellular loop of LptD adopting a ―plug and barrel‖ architecture [81]. As LptE also binds LPS 
in vitro [63], this finding suggests a dual role for this protein: a structural component of the LptDE 
complex and a recognition site for LPS at the OM [63,81]. In a more recent work, the same group 
identified the regions in LptA, LptC, and in the N-terminal domain of LptD that mediate contacts 
between the proteins and thus are implicated in the formation of the transenvelope  bridge. These 
studies showed that in vivo LptA contacts LptC at the IM via its N-terminal region and LptD at the OM 
via its C-terminal region thus creating a continuous bridge of antiparallel β-strands between IM and 
OM [64]. Indeed, LptA and LptC belong to the same OstA superfamily of the N-terminal domain of 
LptD and, as mentioned above, share a very similar three dimensional structure [66,69]. Interestingly, 
the periplasmic but not the transmembrane domain of LptC appears to be also required for interaction 
with the IM transporter LptBFG [82]. As the periplasmic loop of LptF and LptG are predicted to 
assume  the  β-jellyroll  structure  shared  by  LptA,  LptC  and  LptD  it  has  been  proposed  that  the 
transenvelope bridge is based on the conserved structurally homologous jellyroll domain shared by 
five out of the seven Lpt components [82]. These observations are in agreement with the genomic 
evidence that many Gram-negative organisms encode predicted fusion proteins containing as many as 
four OstA superfamily domains [83]. It is not yet known how many LptA molecules compose the Mar. Drugs 2014, 12  1032 
 
 
transenvelope  bridges.  In  the  work  by  Freinkman  and  coworkers,  the  residues  identified  for  
LptA-LptA dimer interaction are the same involved in LptA interaction with LptC or LptD and the 
authors claim that this could be an artifact due to LptA overexpression [64]. Based on structural data, it 
has  been  suggested  that  four  OstA  superfamily  domains  are  necessary  to  span  the  width  of  the 
periplasm [66]: if LptC and LptD periplasmic domains are taken into account, LptA would function as 
a  dimer  within  the  transenvelope  bridge.  Alternatively,  the  periplasm  could  be  constricted  in  the 
vicinity of Lpt bridges, and thus only one LptA molecule would be sufficient to build the bridge. 
Finally, Okuda and co-worker developed a system to dissect LPS transport into different steps, 
shedding light into the role of ATP hydrolysis during the transport process [68]. In this work, the 
authors identified different sites inside the β-jellyroll structure of LptA and LptC that are involved in 
LPS interaction in vivo, confirming that the periplasmic transit of LPS occurs inside the hydrophobic 
groove formed by the oligomeric protein bridge. More interestingly, the authors suggested that LPS 
transits along Lpt components in an ordered process that requires LptBFG to transfer LPS to LptC and 
then LptBFGC to deliver LPS to LptA. Remarkably, energy (ATP hydrolysis) is not required for 
assembly of the bridge, instead two energy dependent steps are necessary to translocate LPS from IM 
to OM: the first requiring energy step is the extraction of LPS from the IM and the second is the 
transfer of LPS from LptC to LptA. In conclusion, the current model of LPS transport suggests that 
ATP hydrolysis is used to push a continuous stream of LPS through the transenvelope Lpt bridge in 
discrete steps against a concentration gradient [68]. 
3.3. Regulation of Lpt Complex Assembly and LPS Transport Process 
As discussed above, LPS is a crucial structural component of the bacterial OM that it is responsible 
of the permeability barrier proprieties of this membrane [12]. Moreover, this complex glycolipid is 
also believed to function as a molecular chaperone for OMPs assembly: for example, LPS has an 
established role in trimerization of OmpC and OmpF porins [84–86], and it is required for maintaining 
their proper channel gating function [87]. Due to the important roles played by LPS at the OM and the 
dangerous  consequences  of  impaired  transport  of  this  molecule  to  the  cell  surface  (for  instance, 
accumulation of LPS in the IM could influence the proper assembly of essential IM proteins that can 
be lethal for cells), it is not surprising that the bacteria have evolved a fine tuned quality control system 
to  avoid  LPS  mistargeting  during  OM  biogenesis.  In  E.  coli  this  system  comprises  a  panoply  of 
chaperones assisting the assembly of the LPS OM translocon (LptDE) and molecular mechanisms to 
ensure that only functional OM translocons are coupled to active Lpt transenvelope bridges allowing 
LPS translocation from IM to OM. 
LptD is an OM protein with a large periplasmic N-terminal domain, which is essential for its function 
in vivo [63], and contains four cysteine residues, two in the N-terminal and two in the C-terminal 
domain  of  the  protein  [54,88],  implicated  in  the  formation  of  two  non  consecutive  interdomain 
disulfide bonds. Being an OMP, LptD is synthesized in the cytoplasm with an N-terminal cleavable 
signal peptide that allows its transport across the SEC translocon [89]. After secretion across the IM, 
the signal peptide-processed LptD is transported along the aqueous and oxidizing environment of the 
periplasm with the aid of chaperones to be finally delivered to the BAM machinery that inserts it into 
the OM (see above), [22]. The main chaperone involved in LptD folding is SurA [90]. ∆surA mutant Mar. Drugs 2014, 12  1033 
 
 
displays lower LptD level and severe OM perturbations, typical phenotypes of mutants impaired in 
LPS transport [21]. It has been recently demonstrated that the chaperone Skp, belonging to a secondary 
periplasmic folding pathway together with the chaperone/protease DegP [21,91], acts in concert with 
SurA to efficiently assemble LptD. The role performed by Skp is masked when another chaperone 
protein, FkpA, is present in the cell. Interestingly, Skp has a role different from that played by SurA, as 
overexpression  of  SurA  cannot  restore  LptD  biogenesis  in  ∆skp  ∆fkpA  double  mutants  [92].  The 
unique role of Skp/FkpA in LptD biogenesis seems to be correlated with the presence of the large 
periplasmic  N-terminal  domain,  which  is  the  first  to  emerge  into  the  periplasm  during  LptD 
translocation. This would fit well with the observation that Skp association to OMPs occurs at the  
IM [93]. Based on these results, it is not surprising that FhuA, a protein with a similar structure of 
LptD, depends on the same group of chaperones for its folding [92]. 
However, the complex folding process of LptD must take into account two additional proprieties of 
the mature LPS OM translocon: the interaction with LptE and the presence of disulfide bonds. First of 
all, in the mature translocon the lipoprotein LptE resides inside the lumen of the C-terminal domain of 
LptD and this interaction is required for the correct folding of LptD β-barrel into the OM by the Bam 
complex [81,94]. LptDE complex folding is further challenged by the fact that LptD contains two 
disulfide bonds whose correct formation is required to build a functional translocon [88]. Periplasmic 
oxidase DsbA is involved in the formation of disulfide bonds in LptD [95], however the first oxidized 
folding  intermediate  of  LptD  is  not  active  as  it  presents  a  disulfide  bond  between  the  first  two  
N-terminal consecutive cysteines [96]. Interaction with LptE to form the ―plug and barrel‖ architecture 
triggers the conversion of this non-functional intermediate to mature LptD possessing native disulfide 
bonds between non-consecutive cysteines. Therefore interaction of LptE with LptD ultimately controls 
the activation of the LptDE traslocon. Interestingly, LptD folds its β-barrel structure before disulfide 
bonds  rearrangement  and  this  folding  is  rate-limiting  for  its  maturation  [96].  Such  non-functional 
folding intermediate is crucial to avoid LPS mistargeting: LptDE translocon becomes active only if 
both components are correctly synthesized, targeted and assembled together in the OM. This kind of 
regulatory mechanism is crucial to coordinate the assembly of a translocon whose components must 
follow different transport pathways (chaperones/BAM for LptD and Lol for LptE) to reach the final 
destination at the OM. 
Very recently, an additional quality control system that assists LptDE translocon folding/oxidation 
has been identified: it relies on the chaperone/protease BepA. BepA has been proposed to promote 
efficient LptD-LptE interaction at the Bam complex, as overexpression of LptE suppresses the delay in 
LptD disulfide bonds rearrangement observed in ∆bepA mutant and as BepA itself physically and 
genetically  interacts  with  BamA  [97].  Interestingly,  in  ∆bepA  mutant  the  LptD  non-functional 
intermediate with non native disulfide bonds is stabilized and overexpression of protease-dead BepA 
mutants  does  not  completely  rescue  LptDE  translocon  functionality,  suggesting  that  the  protease 
activity of BepA is required to degrade LptD when it fails to be correctly inserted into the OM [97]. 
There is a strong link between LptDE translocon folding and Lpt transenvelope complex assembly. 
It has been demonstrated that the N-terminal domain of LptD has the essential function of connecting 
the OM translocon to the transenvelope bridge assembly by interacting with the C-terminal region of 
LptA [64]. However, in vivo this interaction can occurs only when at least one native disulfide bond is 
formed in LptD [64] that ultimately depends on the proper interaction between LptD and LptE [96]. Mar. Drugs 2014, 12  1034 
 
 
This suggests the existence of a regulatory mechanism where the C-terminal β-barrel domain of LptD 
prevents the N-terminal periplasmic domain from interacting with LptA when its plug domain (LptE) 
is not properly inserted. Accordingly, it has been shown that mutations impairing LptE plug function 
result in defective LPS transport and, as a consequence, in OM barrier perturbations [98]. The existence 
of such regulatory mechanism is in line with the observation that upon LptC, LptD, or LptE depletion 
LptA is degraded and LPS accumulates at the IM [61,74]. Moreover it is known that mutations in LptC 
impairing interaction with LptBFG fail to recruit LptA and therefore to assemble the Lpt transenvelope 
complex  [82].  Overall  these  data  suggest  that  the  cell  cannot  tolerate  the  formation  of  defective 
transenvelope bridges or the leakage of LPS molecules within the periplasm. 
The importance of mechanisms that monitor the proper delivery of LPS to the cell surface is also 
outlined by a recently identified dedicated surveillance system that detects directly LPS mistargeting 
and triggers the envelope stress response [99]. 
In E. coli OM integrity is monitored by an envelope stress response system that relies on activation 
of  the  essential  alternative  σ  factor  (σ
E)  which  controls  the  expression  of  genes  required  for  
damage-repair pathways [100]. Notably, LptA [101] and LptD [102] belong to the σ
E regulon. Under 
non-stress conditions, σ
E is kept inactive at the cytoplasmic site of the IM by the negative regulator 
RseA through binding to its cytoplasmic domain. RseA is a single-pass IM protein whose periplasmic 
domain binds the regulatory protein RseB and this binding enhances σ
E inhibition [103,104]. When an 
OM  stress  occurs,  the  OMPs  cannot  be  properly  folded  and  accumulate  into  the  periplasm.  The  
C-terminal residues of unfolded OMPs interact with the protease DegS activating the cleavage of  
RseA  [105].  Following  the  proteolytic  cleavage  of  the  periplasmic  region  of  RseA  by  DegS,  the 
multipass  IM  protease  RseP  cleaves  the  transmembrane  region  of  RseA  thus  freeing  σ
E  [100]. 
However, RseA cleavage by activated DegS is prevented by RseB binding to RseA [103,104,106]. A 
recent  work  by  Lima  and  co-workers  demonstrated  that  the  cell  senses  defects  in  LPS  transport 
through LPS binding by RseB in the periplasm and that LPS-RseB interaction results in RseA-RseB, 
dissociation allowing RseA cleavage by DegS with consequent σ
E activation [99]. This two-signals 
regulation appears a strategy adopted by the cell to ensure a precise homeostatic control of the barrier 
function  of  the  OM  and  reflects  the  strict  connection  between  the  biogenesis  of  its  different 
components, as defects in LPS biogenesis are expected to generate problems with OMPs assembly and 
vice versa. 
4. Conclusions 
LPS is an essential hallmark of the OM in the majority of Gram-negative bacteria species. The 
reason why this complex glycolipid is essential for these bacteria is object of a long-standing debate, 
as  certain  genera  of  Gram-negatives  do  not  require  LPS  to  assemble  a  functional  OM  and  to  
survive [107,108]. What is clear is that the asymmetry of the OM, ensured by the presence of LPS in 
its outer leaflet, is fundamental for the barrier proprieties of the OM that contribute to the generalized 
resistance of Gram-negative bacteria to several antibiotics and allow Enterobacteria to colonize the 
gut, where high concentration of detergent-like molecules as bile salts need to be tolerated [12]. LPS is 
a  potent  activator  of  the  innate  immune  response  and  an  important  virulence  factor,  making  its 
maturation and assembly at the OM a problem of high biological relevance. Mar. Drugs 2014, 12  1035 
 
 
The work of the past 10 years has allowed the discovery of the transenvelope protein machinery 
that transports the amphipathic LPS molecules across the periplasm at the expense of ATP hydrolysis. 
Remarkably, the assembly of this machine is finely regulated to ensure correct and co-ordinated OM 
synthesis. However, several questions remain to be solved. For instance, it is not clear whether the 
transenvelope structure is always present in the cell or if it is only transiently built and, in this case, 
whether the presence of LPS in the outer leaflet of the IM is the signal that triggers bridges formation. 
Moreover, while the interaction between the OM translocon and LptA has been characterized in detail, 
the assembly of the IM LptBFGC sub-complex and its interaction with LptA is not fully understood. 
Additional  unsolved  problem  are  the  number  and  arrangements  of  LptA  molecules  in  the 
transenvelope bridge, as well as the mechanism of LPS insertion in the OM by LptDE. Finally, the 
studies on LPS export have been performed using  E. coli K12 strains, that produce a rough-type  
LPS [43,44], but it is conceivable that in naturally occurring strains the addition of the O-antigen 
moiety to the core-lipid A would generate a considerable steric hindrance. Is some other unknown 
protein/protein  complex  involved  to  the  transport  of  such  bulky  molecules  within  the  periplasm? 
Interestingly, it has been suggested that under specific growth conditions the macrolide transporter 
MacAB-TolC [109] might be involved in LPS transport to the cell surface, as MacA has been shown to 
contain  two  LPS  binding  sites  that  are  essential  for  the  functionality  of  the  transporter  in  drug 
resistance  in  vivo  and  for  ATPase  activity  stimulation  in  vitro  [110].  It  would  be  interesting  to 
investigate whether this or other apparently non-related transporters might in turn become essential for 
growth in strains producing a smooth-type LPS. 
It is clear that we are still far from drawing the complete picture of the molecular mechanisms of 
LPS  transport  within  bacterial  envelope  and  further  studies  exploiting  innovative  strategies  are,  
thus, required. 
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